A New Frontier: Innovative Approach to Cardiometabolic Health
Achieving optimal cardiometabolic health is not exactly a walk in the park. In fact, it’s widely stated that only 6.8% of American adults have achieved it – taken from research conducted before the Covid-19 pandemic1. With the emphasis on ultra-processed foods in Western diets and consumers often strapped for time, is there a way to […]
ProBiotix Health signs partner agreement with SymbioPharm
ProBiotix Health Plc (‘ProBiotix’), a life sciences company that develops probiotic formulations to support cardiometabolic health, has entered into a new partnership agreement with SymbioPharm that enables the dietary supplement brand to utilise the CholBiome®CH formulation from ProBiotix to target and reduce cholesterol in its branded range of consumer products. SymbioPharm, the pioneering German company specialising […]
ProBiotix Health highlights LPLDL® and new products to support cardiometabolic health at SupplySide West
ProBiotix Health plc (‘ProBiotix’) will be highlighting the advantages of LPLDL®, its patented science-backed probiotic strain for cardiometabolic health in a range of new formats at this year’s biggest tradeshow for food and dietary supplement manufacturers, SupplySide West, held in Mandalay Bay, Las Vegas. On 25 and 26 October, ProBiotix will use the event to […]
ProBiotix Health launches new dual-action cholesterol reducing bi-layer tablet CholBiome®CH at Vitafoods Europe
ProBiotix Health plc (‘ProBiotix’), a global market leader in microbiome modulation technology in the life sciences industry, has added to its growing range of science-backed cholesterol-reducing products with CholBiome®CH. The latest innovation from ProBiotix, which will launch at Vitafoods Europe this year, is a result of new regulations from the European Food Safety Authority (EFSA) […]
